{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:05:08Z","timestamp":1790636708114,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224894\/Z\/21\/Z"],"award-info":[{"award-number":["224894\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221782\/Z\/20\/Z"],"award-info":[{"award-number":["221782\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-024200"],"award-info":[{"award-number":["INV-024200"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Additive genetic models are the default for genome-wide association studies, but deviations from additivity are crucial for understanding disease mechanisms and therapeutic responses. Yet existing methods for testing nonadditivity are computationally infeasible for large-scale analysis or rely on Hardy-Weinberg assumptions, making them unsuitable for rare variants in large biobanks. We use an orthogonal allelic recoding framework that enables scalable testing of nonadditive genetic effects without Hardy-Weinberg assumptions while integrating seamlessly with existing linear mixed models. Analyzing\u00a0up to 399,943 UK Biobank individuals across 2906 plasma proteins and 55 quantitative traits, we demonstrate that approximately one-third of cognate gene-protein relationships exhibit nonlinear dose responses. We identify recessive effects, including\n                    <jats:italic>FUT10<\/jats:italic>\n                    variants associated with reduced lung function, and validate these findings in the All of Us cohort. We show that many complex traits show partial recessivity, reconciling conflicting inheritance patterns in the literature, and that joint two-degree-of-freedom models substantially improve statistical power when the underlying trait is partially recessive. Our framework efficiently partitions additive and nonadditive heritability components at biobank scale, providing a quantitative map of gene dose-response relationships with direct implications for therapeutic target identification and precision medicine.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-76151-w","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:53:27Z","timestamp":1787990007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deviations from genetic additivity driven by rare variants at biobank scale"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-209X","authenticated-orcid":false,"given":"Frederik H.","family":"Lassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7680-1208","authenticated-orcid":false,"given":"Samvida S.","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-374X","authenticated-orcid":false,"given":"Nikolas A.","family":"Baya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M.","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-0047","authenticated-orcid":false,"given":"Duncan S.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"76151_CR1","doi-asserted-by":"publisher","first-page":"e1000008","DOI":"10.1371\/journal.pgen.1000008","volume":"4","author":"WG Hill","year":"2008","unstructured":"Hill, W. G., Goddard, M. E. & Visscher, P. M. Data and theory point to mainly additive genetic variance for complex traits. PLOS Genet. 4, e1000008 (2008).","journal-title":"PLOS Genet."},{"key":"76151_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ajhg.2015.01.001","volume":"96","author":"Z Zhu","year":"2015","unstructured":"Zhu, Z. et al. Dominance genetic variation contributes little to the missing heritability for human complex traits. Am. J. Hum. Genet. 96, 377\u2013385 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"76151_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11724-6","volume":"10","author":"L Yengo","year":"2019","unstructured":"Yengo, L., Wray, N. R. & Visscher, P. M. Extreme inbreeding in a European ancestry sample from the contemporary UK population. Nat. Commun. 10, 3719 (2019).","journal-title":"Nat. Commun."},{"key":"76151_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1126\/science.abn8455","volume":"379","author":"DS Palmer","year":"2023","unstructured":"Palmer, D. S. et al. Analysis of genetic dominance in the UK Biobank. Science 379, 1341\u20131348 (2023).","journal-title":"Science"},{"key":"76151_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrg1826","volume":"7","author":"SE Antonarakis","year":"2006","unstructured":"Antonarakis, S. E. & Beckmann, J. S. Mendelian disorders deserve more attention. Nat. Rev. Genet. 7, 277\u2013282 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"76151_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd4051","volume":"12","author":"RM Plenge","year":"2013","unstructured":"Plenge, R. M., Scolnick, E. M. & Altshuler, D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 12, 581\u2013594 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"76151_CR7","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","volume":"365","author":"BW Ramsey","year":"2011","unstructured":"Ramsey, B. W. et al. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation. N. Engl. J. Med. 365, 1663\u20131672 (2011).","journal-title":"N. Engl. J. Med."},{"key":"76151_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.biocel.2014.02.023","volume":"52","author":"P Fanen","year":"2014","unstructured":"Fanen, P., Wohlhuter-Haddad, A. & Hinzpeter, A. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies. Int. J. Biochem. Cell Biol. 52, 94\u2013102 (2014).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"76151_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/ATVBAHA.117.310675","volume":"38","author":"RD Santos","year":"2018","unstructured":"Santos, R. D. Expression of LDLRs (low-density lipoprotein receptors), dyslipidemia severity, and response to PCSK9 (proprotein convertase subtilisin kexin type 9) inhibition in homozygous familial hypercholesterolemia. Arterioscle. Thromb. Vasc. Biol. 38, 481\u2013483 (2018).","journal-title":"Arterioscle. Thromb. Vasc. Biol."},{"key":"76151_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41586-022-05420-7","volume":"613","author":"HO Heyne","year":"2023","unstructured":"Heyne, H. O. et al. Mono- and biallelic variant effects on disease at biobank scale. Nature 613, 519\u2013525 (2023).","journal-title":"Nature"},{"key":"76151_CR11","doi-asserted-by":"crossref","unstructured":"Koyama, S. et al. Exome-wide association study of blood lipids in 1,158,017 individuals from diverse populations. Nat. Genet. 58, 1268\u20131279 (2026).","DOI":"10.1038\/s41588-026-02613-y"},{"key":"76151_CR12","doi-asserted-by":"crossref","unstructured":"Heng, T. H. et al. Widespread recessive effects on common diseases in a cohort of 44,000 British Pakistanis and Bangladeshis with high autozygosity. Am. J. Hum. Genet. 112, 1316\u20131329 (2025).","DOI":"10.1016\/j.ajhg.2025.03.020"},{"key":"76151_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ajhg.2021.03.018","volume":"108","author":"A Pazokitoroudi","year":"2021","unstructured":"Pazokitoroudi, A., Chiu, A. M., Burch, K. S., Pasaniuc, B. & Sankararaman, S. Quantifying the contribution of dominance deviation effects to complex trait variation in biobank-scale data. Am. J. Hum. Genet. 108, 799\u2013808 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"76151_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1086\/429864","volume":"76","author":"JE Wigginton","year":"2005","unstructured":"Wigginton, J. E., Cutler, D. J. & Abecasis, G. R. A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76, 887\u2013893 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"76151_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/gepi.20335","volume":"32","author":"M Li","year":"2008","unstructured":"Li, M. & Li, C. Assessing departure from Hardy-Weinberg equilibrium in the presence of disease association. Genet. Epidemiol. 32, 589\u2013599 (2008).","journal-title":"Genet. Epidemiol."},{"key":"76151_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1515\/sagmb-2012-0039","volume":"12","author":"J Graffelman","year":"2013","unstructured":"Graffelman, J. & Moreno, V. The mid p-value in exact tests for Hardy-Weinberg equilibrium. Stat. Appl. Genet. Mol. Biol. 12, 433\u2013448 (2013).","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"76151_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1469-185X.1997.tb00011.x","volume":"72","author":"O Mayo","year":"1997","unstructured":"Mayo, O. & B\u00fcrger, R. The evolution of dominance: a theory whose time has passed? Biol. Rev. 72, 97\u2013110 (1997).","journal-title":"Biol. Rev."},{"key":"76151_CR18","first-page":"1959","volume":"57","author":"JAGM de Visser","year":"2003","unstructured":"de Visser, J. A. G. M. et al. Perspective: evolution and detection of genetic robustness. Evolution 57, 1959\u20131972 (2003).","journal-title":"Evolution"},{"key":"76151_CR19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1534\/genetics.111.132944","volume":"189","author":"F Manna","year":"2011","unstructured":"Manna, F., Martin, G. & Lenormand, T. Fitness landscapes: an alternative theory for the dominance of mutation. Genetics 189, 923\u2013937 (2011).","journal-title":"Genetics"},{"key":"76151_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","volume":"627","author":"AG Bick","year":"2024","unstructured":"Bick, A. G. et al. Genomic data in the All of Us Research Program. Nature 627, 340\u2013346 (2024).","journal-title":"Nature"},{"key":"76151_CR21","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41588-023-01415-w","volume":"55","author":"RJ Hofmeister","year":"2023","unstructured":"Hofmeister, R. J., Ribeiro, D. M., Rubinacci, S. & Delaneau, O. Accurate rare variant phasing of whole-genome and whole-exome sequencing data in the UK Biobank. Nat. Genet. 55, 1243\u20131249 (2023).","journal-title":"Nat. Genet."},{"key":"76151_CR22","doi-asserted-by":"crossref","unstructured":"Lassen, F. H. et al. Exome-wide evidence of compound heterozygous effects across common phenotypes in the UK Biobank. Cell Genom. 4,https:\/\/www.cell.com\/cell-genomics\/abstract\/S2666-979X(24)00196-4 (2024).","DOI":"10.1016\/j.xgen.2024.100602"},{"key":"76151_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1534\/genetics.106.067348","volume":"176","author":"JM \u00c1lvarez-Castro","year":"2007","unstructured":"\u00c1lvarez-Castro, J. M. & Carlborg,\u00a0\u00d6. A unified model for functional and statistical epistasis and its application in quantitative trait loci analysis. Genetics 176, 1151\u20131167 (2007).","journal-title":"Genetics"},{"key":"76151_CR24","unstructured":"Falconer, D. S. Introduction To Quantitative Genetics 4th Edition (1996)."},{"key":"76151_CR25","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","volume":"53","author":"J Mbatchou","year":"2021","unstructured":"Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097\u20131103 (2021).","journal-title":"Nat. Genet."},{"key":"76151_CR26","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41588-022-01178-w","volume":"54","author":"W Zhou","year":"2022","unstructured":"Zhou, W. et al. SAIGE-GENE+ improves the efficiency and accuracy of set-based rare variant association tests. Nat. Genet. 54, 1466\u20131469 (2022).","journal-title":"Nat. Genet."},{"key":"76151_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"76151_CR28","doi-asserted-by":"crossref","unstructured":"Drouard, G. et al. Twin study provides heritability estimates for 2321 plasma proteins and assesses missing SNP heritability. J. Proteome Res. 24, 2689\u20132697 (2024).","DOI":"10.1021\/acs.jproteome.4c00971"},{"key":"76151_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41586-023-06547-x","volume":"622","author":"RS Dhindsa","year":"2023","unstructured":"Dhindsa, R. S. et al. Rare variant associations with plasma protein levels in the UK Biobank. Nature 622, 339\u2013347 (2023).","journal-title":"Nature"},{"key":"76151_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41588-024-01965-7","volume":"57","author":"N Scherer","year":"2025","unstructured":"Scherer, N. et al. Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat. Genet. 57, 193\u2013205 (2025).","journal-title":"Nat. Genet."},{"key":"76151_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tig.2005.01.007","volume":"21","author":"MF Wilkinson","year":"2005","unstructured":"Wilkinson, M. F. A new function for nonsense-mediated mRNA-decay factors. Trends Genet. 21, 143\u2013148 (2005).","journal-title":"Trends Genet."},{"key":"76151_CR32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/bmj.1.4857.290","volume":"1","author":"AC Allison","year":"1954","unstructured":"Allison, A. C. Protection afforded by sickle-cell trait against subtertian malarial infection.  Br. Med. J. 1, 290\u2013294 (1954).","journal-title":"Br. Med. J."},{"key":"76151_CR33","doi-asserted-by":"publisher","first-page":"166166","DOI":"10.1016\/j.bbadis.2021.166166","volume":"1867","author":"D Roos","year":"2021","unstructured":"Roos, D. & De Boer, M. Mutations in cis that affect mRNA synthesis, processing and translation. Biochim. Biophys. Acta Mol. Basis Dis. 1867, 166166 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"76151_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/msb.2011.14","volume":"7","author":"H Gingold","year":"2011","unstructured":"Gingold, H. & Pilpel, Y. Determinants of translation efficiency and accuracy. Mol. Syst. Biol. 7, 481 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"76151_CR35","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkx973","volume":"46","author":"M Krassowski","year":"2018","unstructured":"Krassowski, M. et al. ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins. Nucleic Acids Res. 46, D901\u2013D910 (2018).","journal-title":"Nucleic Acids Res."},{"key":"76151_CR36","doi-asserted-by":"publisher","first-page":"698\u2013709","DOI":"10.1016\/j.jaci.2019.05.010","volume":"144","author":"A Saku","year":"2019","unstructured":"Saku, A. et al. Fucosyltransferase 2 induces lung epithelial fucosylation and exacerbates house dust mite-induced airway inflammation. J. Allergy Clin. Immunol. 144, 698\u2013709 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"76151_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1165\/rcmb.2024-0216OC","volume":"72","author":"N Hara","year":"2025","unstructured":"Hara, N. et al. Requirement for fucosyltransferase 2 in allergic airway hyperreactivity and mucus obstruction. Am. J. Respir. Cell Mol. Biol. 72, 408\u2013417 (2025).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"76151_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0581-2","volume":"18","author":"A Manichaikul","year":"2017","unstructured":"Manichaikul, A. et al. Genome-wide association study of subclinical interstitial lung disease in MESA. Respir. Res. 18, 97 (2017).","journal-title":"Respir. Res."},{"key":"76151_CR39","doi-asserted-by":"crossref","unstructured":"The Emerging Risk Factors Collaboration* Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302, 1993\u20132000 (2009).","DOI":"10.1001\/jama.2009.1619"},{"key":"76151_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pathol.2018.10.017","volume":"51","author":"SJ Nicholls","year":"2019","unstructured":"Nicholls, S. J. & Nelson, A. J. HDL and cardiovascular disease. Pathology 51, 142\u2013147 (2019).","journal-title":"Pathology"},{"key":"76151_CR41","doi-asserted-by":"crossref","unstructured":"Carlson, J. C. et al. A stop-gain variant in BTNL9 is associated with atherogenic lipid profiles. Hum. Genet. Genom. Adv. 4,https:\/\/www.cell.com\/hgg-advances\/abstract\/S2666-2477(22)00072-0 (2023).","DOI":"10.1016\/j.xhgg.2022.100155"},{"key":"76151_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng.2926","volume":"46","author":"OL Holmen","year":"2014","unstructured":"Holmen, O. L. et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat. Genet. 46, 345\u2013351 (2014).","journal-title":"Nat. Genet."},{"key":"76151_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ajhg.2019.01.002","volume":"104","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. ACAT: A fast and powerful p-value combination method for rare-variant analysis in sequencing studies.  Am. J. Hum. Genet. 104, 410\u2013421 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"76151_CR44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/01621459.2018.1554485","volume":"115","author":"Y Liu","year":"2020","unstructured":"Liu, Y. & Xie, J. Cauchy combination test: a powerful test with analytic p-Value calculation under arbitrary dependency structures. J. Am. Stat. Assoc. 115, 393\u2013402 (2020).","journal-title":"J. Am. Stat. Assoc."},{"key":"76151_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-1-57","volume":"1","author":"AB Gjuvsland","year":"2007","unstructured":"Gjuvsland, A. B., Plahte, E. & Omholt, S. W. Threshold-dominated regulation hides genetic variation in gene expression networks. BMC Syst. Biol. 1, 57 (2007).","journal-title":"BMC Syst. Biol."},{"key":"76151_CR46","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/msb.2012.40","volume":"8","author":"S Stingele","year":"2012","unstructured":"Stingele, S. et al. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol. Syst. Biol. 8, 608 (2012).","journal-title":"Mol. Syst. Biol."},{"key":"76151_CR47","doi-asserted-by":"publisher","first-page":"22130","DOI":"10.1002\/cam4.6719","volume":"12","author":"DM Bravo-Estupi\u00f1an","year":"2023","unstructured":"Bravo-Estupi\u00f1an, D. M. et al. Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer. Cancer Med. 12, 22130\u201322155 (2023).","journal-title":"Cancer Med."},{"key":"76151_CR48","unstructured":"Hail Team. Hail https:\/\/github.com\/hail-is\/hail (2022)."},{"key":"76151_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"key":"76151_CR50","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","volume":"27","author":"H Li","year":"2011","unstructured":"Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27, 2987\u20132993 (2011).","journal-title":"Bioinformatics"},{"key":"76151_CR51","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/bioinformatics\/btu356","volume":"30","author":"H Li","year":"2014","unstructured":"Li, H. Toward better understanding of artifacts in variant calling from high-coverage samples. Bioinformatics 30, 2843\u20132851 (2014).","journal-title":"Bioinformatics"},{"key":"76151_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"76151_CR53","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"76151_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, giab008 (2021).","journal-title":"GigaScience"},{"key":"76151_CR55","unstructured":"Harrell, F. E. Jr. Hmisc: Harrell Miscellaneous. R package version 4.7 (2022)."},{"key":"76151_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"76151_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00803-9","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu, X., Li, C., Mou, C., Dong, Y. & Tu, Y. dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med. 12, 103 (2020).","journal-title":"Genome Med."},{"key":"76151_CR58","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013D894 (2019).","journal-title":"Nucleic Acids Res."},{"key":"76151_CR59","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis, N. M. et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.  Am. J. Hum. Genet. 99, 877\u2013885 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"76151_CR60","doi-asserted-by":"publisher","first-page":"535\u2013548","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan, K. et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell 176, 535\u2013548 (2019).","journal-title":"Cell"},{"key":"76151_CR61","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","volume":"604","author":"J Morales","year":"2022","unstructured":"Morales, J. et al. A joint NCBI and EMBL-EBI transcript set for clinical genomics and research. Nature 604, 310\u2013315 (2022).","journal-title":"Nature"},{"key":"76151_CR62","doi-asserted-by":"publisher","first-page":"D942","DOI":"10.1093\/nar\/gkac1071","volume":"51","author":"A Frankish","year":"2023","unstructured":"Frankish, A. et al. GENCODE: reference annotation for the human and mouse genomes in 2023. Nucleic Acids Res. 51, D942\u2013D949 (2023).","journal-title":"Nucleic Acids Res."},{"key":"76151_CR63","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","volume":"109","author":"V Pejaver","year":"2022","unstructured":"Pejaver, V. et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria.  Am. J. Hum. Genet. 109, 2163\u20132177 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"76151_CR64","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1534\/genetics.113.155176","volume":"195","author":"ZG Vitezica","year":"2013","unstructured":"Vitezica, Z. G., Varona, L. & Legarra, A. On the Additive and Dominant Variance and Covariance of Individuals Within the Genomic Selection Scope. Genetics 195, 1223\u20131230 (2013).","journal-title":"Genetics"},{"key":"76151_CR65","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ajhg.2021.02.014","volume":"108","author":"V Hivert","year":"2021","unstructured":"Hivert, V. et al. Estimation of non-additive genetic variance in human complex traits from a large sample of unrelated individuals.  Am. J. Hum. Genet. 108, 786\u2013798 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"76151_CR66","doi-asserted-by":"crossref","unstructured":"Wik, L. et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol. Cell. Proteomics 20, 100168 (2021).","DOI":"10.1016\/j.mcpro.2021.100168"},{"key":"76151_CR67","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou, W. et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet. 50, 1335\u20131341 (2018).","journal-title":"Nat. Genet."},{"key":"76151_CR68","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41588-020-0621-6","volume":"52","author":"W Zhou","year":"2020","unstructured":"Zhou, W. et al. Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts. Nat. Genet. 52, 634\u2013639 (2020).","journal-title":"Nat. Genet."},{"key":"76151_CR69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ajhg.2011.05.029","volume":"89","author":"MC Wu","year":"2011","unstructured":"Wu, M. C. et al. Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test. Am. J. Hum. Genet. 89, 82\u201393 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"76151_CR70","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/biostatistics\/kxs014","volume":"13","author":"S Lee","year":"2012","unstructured":"Lee, S., Wu, M. C. & Lin, X. Optimal tests for rare variant effects in sequencing association studies. Biostatistics 13, 762\u2013775 (2012).","journal-title":"Biostatistics"},{"key":"76151_CR71","doi-asserted-by":"publisher","first-page":"e1005165","DOI":"10.1371\/journal.pgen.1005165","volume":"11","author":"L Moutsianas","year":"2015","unstructured":"Moutsianas, L. et al. The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex disease. PLOS Genet. 11, e1005165 (2015).","journal-title":"PLOS Genet."},{"key":"76151_CR72","unstructured":"Braun, M. sparseMVN: Multivariate normal functions for sparse covariance and precision matrices https:\/\/cran.r-project.org\/web\/packages\/sparseMVN\/index.html (2021)."},{"key":"76151_CR73","doi-asserted-by":"publisher","unstructured":"Lassen, F. & Palmer, D. Deviations from genetic additivity driven by rare variants at biobank scale. Summary Statistics. Zenodo https:\/\/doi.org\/10.5281\/zenodo.18944247 (2026).","DOI":"10.5281\/zenodo.18944247"},{"key":"76151_CR74","doi-asserted-by":"publisher","unstructured":"Lassen, F. H. Scripts for Deviations from genetic additivity driven by rare variants at biobank scale. Zenodo https:\/\/doi.org\/10.5281\/zenodo.19457056 (2026).","DOI":"10.5281\/zenodo.19457056"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76151-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76151-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76151-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:50:47Z","timestamp":1790635847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76151-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76151"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76151-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.H.L is a director and shareholder at Omos Biosciences Ltd., but conducted this work as a student at the University of Oxford. S.S.V is an employee of Illumina Inc., but conducted this work while employed by the University of Oxford. C.M.L. is a part-time employee of Population Health Partners, owns equity in Population Health Partners and its subsidiaries, reports grants from Bayer AG and Novo Nordisk and has a partner who works at Vertex. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10302"}}